Clonidine Titration for PTSD-Related Sleep Disruption and Anxiety
Start clonidine at 0.1 mg at bedtime, then increase by 0.1 mg every few days to weekly intervals as tolerated, targeting a total daily dose of 0.2-0.6 mg divided into twice-daily dosing (morning and bedtime), with careful monitoring for orthostatic hypotension.
Starting Dose and Initial Titration
Begin with 0.1 mg at bedtime 1, 2. This nighttime dosing strategy minimizes daytime sedation while targeting sleep disruption and nightmares—core symptoms in PTSD. The FDA-approved dosing for clonidine supports this conservative starting approach 3.
After 3-7 days at the initial dose, if tolerated and symptoms persist, add a morning dose of 0.1 mg to establish twice-daily dosing 1. This divided dosing pattern (morning and bedtime) is the standard approach documented in PTSD case series.
Maintenance Titration
Continue increasing by 0.1 mg increments at weekly intervals until therapeutic effect is achieved 3. The evidence from PTSD populations shows:
- Average effective dose: 0.2 mg/day (0.1 mg twice daily) 1
- Typical therapeutic range: 0.2-0.6 mg/day in divided doses 4
- Maximum doses rarely exceed 0.6 mg/day in PTSD populations, though the FDA label indicates 2.4 mg/day as the maximum effective dose for hypertension 3
Evidence Quality and Clinical Context
Important caveat: Clonidine carries only a Level C recommendation for PTSD-associated nightmares from the American Academy of Sleep Medicine 4. This reflects the limited evidence base—primarily Level 4 case series rather than randomized controlled trials. Prazosin remains the Level A recommendation for PTSD nightmares, with stronger evidence and typically higher doses (mean 3-13 mg/day) 4.
However, recent retrospective data suggests clonidine may be effective at lower doses than previously documented. A 2021 study of 79 veterans showed 72% improvement in PTSD symptoms with low-dose clonidine (median dose not specified but characterized as "low-dose") 5.
Safety Monitoring
Monitor blood pressure before each dose increase, particularly for:
One case series reported a fall in blood pressure with increasing doses 4. The risk of hypotension is shared with prazosin but has not been as rigorously studied with clonidine 4.
Practical Algorithm
- Week 1: 0.1 mg at bedtime
- Week 2: If tolerated, add 0.1 mg in morning (total 0.2 mg/day divided)
- Week 3+: If inadequate response, increase by 0.1 mg/day weekly
- Target: 0.2-0.6 mg/day total (divided doses)
- Reassess: At 2-4 weeks for therapeutic effect 2
Taking the larger portion at bedtime may minimize daytime sedation 3. For example, if total daily dose is 0.3 mg, consider 0.1 mg morning and 0.2 mg bedtime.
Duration and Expectations
Effects on nightmares and sleep may be observed within days to 2 weeks 1, 6. One case report documented nightmare resolution within 24 hours of restarting clonidine 6. However, full therapeutic effects on PTSD symptoms may require 2-4 weeks 2.
When to Consider Alternatives
If no response at 0.4-0.6 mg/day after 4 weeks, or if side effects are intolerable, strongly consider switching to prazosin, which has Level A evidence and may be more effective for PTSD-specific symptoms 4. The evidence does not support pushing clonidine doses beyond 0.6 mg/day for PTSD, despite higher doses being used for hypertension.